Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05645471 · ClinicalTrials.gov registry record · NA

Together After Cancer

A NA study of Breast Cancer and Quality of Life, sponsored by University of South Florida.

Recruiting
Registry status
NA
Development phase
480
Enrollment target
3
Study locations

NCT05645471 is a NA study of Breast Cancer and Quality of Life that is actively recruiting participants, run by University of South Florida. The registered enrollment target is 480 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (83% lower). The trial reports 3 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05645471, a NA study of Breast Cancer and Quality of Life, is actively recruiting participants, sponsored by University of South Florida.

RECRUITING
Registry status
NA
Development phase
480 participants
Enrollment target
3
Study locations

Study Summary

To evaluate the impact of an adapted online, self-help relationship intervention (supplemented with brief coach calls) for survivors of breast cancer and their partners. Couples will be randomized to receive either the online intervention (Together after Cancer) or usual care (UC) and assessed at baseline, end of the program, and 3 months after randomization.

Interventions

  • BEHAVIORAL Together After Cancer

Study Locations (3)

Florida

  • Sylvester Comprehensive Cancer Center and University of Miami - Miami
  • AdventHealth - Orlando
  • Moffitt Cancer Center - Tampa

Trial Details

FieldValue
Enrollment Target 480 participants
Start Date 2023-01-01
Est. Completion 2026-03-01
Phase NA

Sponsor

University of South Florida

252 total trials

What the Registry Record Tells You About NCT05645471

The ClinicalTrials.gov registry entry for NCT05645471 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 480 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (83% lower). The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Together After Cancer is the first listed.

NCT05645471 reports 3 study locations spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT05645471 about?

NCT05645471 is a clinical study titled "Together After Cancer". To evaluate the impact of an adapted online, self-help relationship intervention (supplemented with brief coach calls) for survivors of breast cancer and their partners. Couples will be randomized to receive either the online intervention (Together after Cancer) or usual care (UC) and assessed at ba...

What is the current status of trial NCT05645471?

This trial is currently recruiting. It is a NA study. The enrollment target is 480 participants. The study started on 2023-01-01. Estimated completion is 2026-03-01.

What conditions does trial NCT05645471 study?

This clinical trial studies the following conditions: Breast Cancer, Quality of Life, Communication.

What interventions are being tested in trial NCT05645471?

The interventions under investigation include: Together After Cancer (BEHAVIORAL).

Who is sponsoring clinical trial NCT05645471?

This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05645471 being conducted?

This trial has 3 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.